Cargando…

Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice

Trimethylamine-N-oxide (TMAO) is a gut microbial metabolite that promotes Alzheimer’s disease (AD) progression. Given that probiotics can alleviate AD symptoms by inhibiting the synthesis of TMAO, here we investigated the correlation between TMAO and cognitive deterioration by measuring TMAO levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qiu-Jun, Shen, Yue-E, Wang, Xin, Fu, Shuang, Zhang, Xin, Zhang, Yi-Na, Wang, Rui-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977692/
https://www.ncbi.nlm.nih.gov/pubmed/31907339
http://dx.doi.org/10.18632/aging.102645
_version_ 1783490566503268352
author Wang, Qiu-Jun
Shen, Yue-E
Wang, Xin
Fu, Shuang
Zhang, Xin
Zhang, Yi-Na
Wang, Rui-Tao
author_facet Wang, Qiu-Jun
Shen, Yue-E
Wang, Xin
Fu, Shuang
Zhang, Xin
Zhang, Yi-Na
Wang, Rui-Tao
author_sort Wang, Qiu-Jun
collection PubMed
description Trimethylamine-N-oxide (TMAO) is a gut microbial metabolite that promotes Alzheimer’s disease (AD) progression. Given that probiotics can alleviate AD symptoms by inhibiting the synthesis of TMAO, here we investigated the correlation between TMAO and cognitive deterioration by measuring TMAO levels in the plasma of choline-treated APP/PS1 mice (an AD mouse model) with and without probiotic treatments. We found that declines in L. plantarum in the gut were associated with cognitive impairment. Moreover, 12-weeks of treatment with memantine plus L. plantarum ameliorated cognitive deterioration, decreased Αβ levels in the hippocampus, and protected neuronal integrity and plasticity. These effects were accompanied by reductions in TMAO synthesis and neuroinflammation. These experiments demonstrate that L. plantarum augments the beneficial therapeutic effects of memantine treatment in APP/PS1 mice by remodeling the intestinal microbiota, inhibiting the synthesis of TMAO, and reducing clusterin levels. Our results thus highlight intestinal microbiota as a potential therapeutic target to decrease the risk of AD.
format Online
Article
Text
id pubmed-6977692
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-69776922020-01-31 Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice Wang, Qiu-Jun Shen, Yue-E Wang, Xin Fu, Shuang Zhang, Xin Zhang, Yi-Na Wang, Rui-Tao Aging (Albany NY) Research Paper Trimethylamine-N-oxide (TMAO) is a gut microbial metabolite that promotes Alzheimer’s disease (AD) progression. Given that probiotics can alleviate AD symptoms by inhibiting the synthesis of TMAO, here we investigated the correlation between TMAO and cognitive deterioration by measuring TMAO levels in the plasma of choline-treated APP/PS1 mice (an AD mouse model) with and without probiotic treatments. We found that declines in L. plantarum in the gut were associated with cognitive impairment. Moreover, 12-weeks of treatment with memantine plus L. plantarum ameliorated cognitive deterioration, decreased Αβ levels in the hippocampus, and protected neuronal integrity and plasticity. These effects were accompanied by reductions in TMAO synthesis and neuroinflammation. These experiments demonstrate that L. plantarum augments the beneficial therapeutic effects of memantine treatment in APP/PS1 mice by remodeling the intestinal microbiota, inhibiting the synthesis of TMAO, and reducing clusterin levels. Our results thus highlight intestinal microbiota as a potential therapeutic target to decrease the risk of AD. Impact Journals 2020-01-06 /pmc/articles/PMC6977692/ /pubmed/31907339 http://dx.doi.org/10.18632/aging.102645 Text en Copyright © 2020 Wang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Wang, Qiu-Jun
Shen, Yue-E
Wang, Xin
Fu, Shuang
Zhang, Xin
Zhang, Yi-Na
Wang, Rui-Tao
Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice
title Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice
title_full Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice
title_fullStr Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice
title_full_unstemmed Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice
title_short Concomitant memantine and Lactobacillus plantarum treatment attenuates cognitive impairments in APP/PS1 mice
title_sort concomitant memantine and lactobacillus plantarum treatment attenuates cognitive impairments in app/ps1 mice
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977692/
https://www.ncbi.nlm.nih.gov/pubmed/31907339
http://dx.doi.org/10.18632/aging.102645
work_keys_str_mv AT wangqiujun concomitantmemantineandlactobacillusplantarumtreatmentattenuatescognitiveimpairmentsinappps1mice
AT shenyuee concomitantmemantineandlactobacillusplantarumtreatmentattenuatescognitiveimpairmentsinappps1mice
AT wangxin concomitantmemantineandlactobacillusplantarumtreatmentattenuatescognitiveimpairmentsinappps1mice
AT fushuang concomitantmemantineandlactobacillusplantarumtreatmentattenuatescognitiveimpairmentsinappps1mice
AT zhangxin concomitantmemantineandlactobacillusplantarumtreatmentattenuatescognitiveimpairmentsinappps1mice
AT zhangyina concomitantmemantineandlactobacillusplantarumtreatmentattenuatescognitiveimpairmentsinappps1mice
AT wangruitao concomitantmemantineandlactobacillusplantarumtreatmentattenuatescognitiveimpairmentsinappps1mice